Search by Drug Name or NDC

    NDC 29273-0402-04 FloLipid 40 mg/5mL Details

    FloLipid 40 mg/5mL

    FloLipid is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Salerno Pharmaceuticals Co.. The primary component is SIMVASTATIN.

    Product Information

    NDC 29273-0402
    Product ID 29273-402_f44563c4-4006-f88b-e053-2a95a90a2beb
    Associated GPIs 39400075001820
    GCN Sequence Number 075977
    GCN Sequence Number Description simvastatin ORAL SUSP 40MG/5ML ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 41192
    HICL Sequence Number 006312
    HICL Sequence Number Description SIMVASTATIN
    Brand/Generic Brand
    Proprietary Name FloLipid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Simvastatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/5mL
    Substance Name SIMVASTATIN
    Labeler Name Salerno Pharmaceuticals Co.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206679
    Listing Certified Through 2024-12-31

    Package

    NDC 29273-0402-04 (29273040204)

    NDC Package Code 29273-402-04
    Billing NDC 29273040204
    Package 150 mL in 1 BOTTLE, GLASS (29273-402-04)
    Marketing Start Date 2017-11-01
    NDC Exclude Flag N
    Pricing Information N/A